Constrained cell penetrating peptides
Tài liệu tham khảo
Svensen, 2012, Peptides for cell-selective drug delivery, Trends Pharm. Sci., 33, 186, 10.1016/j.tips.2012.02.002
Langer, 2001, Drugs on target, Science, 293, 58, 10.1126/science.1063273
Yoo, 2011, Bio-inspired, bioengineered and biomimetic drug delivery carriers, Nat Rev Drug Discov, 10, 521, 10.1038/nrd3499
Duncan, 2010, Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities, Adv Drug Deliv Rev, 62, 272, 10.1016/j.addr.2009.12.005
Majidi, 2009, Target therapy of cancer: implementation of monoclonal antibodies and nanobodies, Hum Antibodies, 18, 81, 10.3233/HAB-2009-0204
Rana, 2012, Monolayer coated gold nanoparticles for delivery applications, Adv Drug Deliv Rev, 64, 200, 10.1016/j.addr.2011.08.006
Frankel, 2016, Cellular uptake of the tat protein from human immunodeficiency virus, Cell, 55, 1189, 10.1016/0092-8674(88)90263-2
Frankel, 1989, Activity of synthetic peptides from the Tat protein of human immunodeficiency virus type 1, PNAS, 86, 7397, 10.1073/pnas.86.19.7397
Jiang, 2004, Tumor imaging by means of proteolytic activation of cell-penetrating peptides, PNAS, 101, 17867, 10.1073/pnas.0408191101
Olson, 2009, In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer, Integr Biol, 1, 382, 10.1039/b904890a
Olson, 2010, Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases, PNAS, 107, 4311, 10.1073/pnas.0910283107
Nguyen, 2010, Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival, PNAS, 107, 4317, 10.1073/pnas.0910261107
Prestel, 2016, Spatio-temporal control of cellular uptake achieved by photoswitchable cell-penetrating peptides, Chem Commun, 52, 701, 10.1039/C5CC06848G
Zhu, 2012, Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting, ACS Nano, 6, 3491, 10.1021/nn300524f
Zhu, 2013, Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety, PNAS, 110, 17047, 10.1073/pnas.1304987110
Hansen, 2012, Constrained and UV-activatable cell-penetrating peptides for intracellular delivery of liposomes, J Control Release, 164, 87, 10.1016/j.jconrel.2012.10.008
Liu, 2014, Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment, Nat Commun, 5, 4280, 10.1038/ncomms5280
Bode, 2015, Enzyme-activatable cell-penetrating peptides through a minimal side chain modification, Bioconjug Chem, 26, 850, 10.1021/acs.bioconjchem.5b00066
Wender, 2000, The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters, PNAS, 97, 13003, 10.1073/pnas.97.24.13003
Jin, 2013, Acid-active cell-penetrating peptides for in vivo tumor-targeted drug delivery, J Am Chem Soc, 135, 933, 10.1021/ja311180x
Lee, 2014, Activatable cell penetrating peptide–peptide nucleic acid conjugate via reduction of azobenzene PEG chains, J Am Chem Soc, 136, 12868, 10.1021/ja507547w
Zhang, 2011, Design of acid-activated cell penetrating peptide for delivery of active molecules into cancer cells, Bioconjug Chem, 22, 1410, 10.1021/bc200138d
Sethuraman, 2007, TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors, J Control Release, 118, 216, 10.1016/j.jconrel.2006.12.008
Bode, 2014, Activation of cell-penetrating peptides by disulfide bridge formation of truncated precursors, Chem Commun, 50, 415, 10.1039/C3CC46826G
Hansen, 2011, A modular and noncovalent transduction system for leucine-zipper-tagged proteins, ChemBioChem, 12, 2294, 10.1002/cbic.201100481
Bode, 2017, Coiled-coil mediated activation of oligo-arginine cell-penetrating peptides, ChemBioChem, 18, 185, 10.1002/cbic.201600614
Copolovici, 2014, Cell-penetrating peptides: design, synthesis, and applications, ACS Nano, 8, 1972, 10.1021/nn4057269
Rothbard, 2002, Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake, J Med Chem, 45, 3612, 10.1021/jm0105676
Fei, 2011, The influence of net charge and charge distribution on cellular uptake and cytosolic localization of arginine-rich peptides, J Drug Target, 19, 675, 10.3109/1061186X.2010.531729
Patil, 2012, Highly efficient (R-X-R)-type carbamates as molecular transporters for cellular delivery, J Am Chem Soc, 134, 7196, 10.1021/ja210026m
Patil, 2014, Second generation, arginine-rich (R–X′–R)4-type cell-penetrating α–ω–α-peptides with constrained, chiral ω-amino acids (X′) for enhanced cargo delivery into cells, Bioorg Med Chem Lett, 24, 4198, 10.1016/j.bmcl.2014.07.040
Madhu, 2017, Cyclic dipeptide based cell-penetrating peptidomimetics for effective DNA delivery, Org Biomol Chem, 15, 3170, 10.1039/C7OB00167C
Potocky, 2005, Effects of conformational stability and geometry of guanidinium display on cell entry by β-peptides, J Am Chem Soc, 127, 3686, 10.1021/ja042566j
Fillon, 2005, Cell penetrating agents based on a polyproline helix scaffold, J Am Chem Soc, 127, 11798, 10.1021/ja052377g
Farrera-Sinfreu, 2005, Cell-penetrating cis-γ-amino-l-proline-derived peptides, J Am Chem Soc, 127, 9459, 10.1021/ja051648k
Nagel, 2017, Effect of preorganized charge-display on the cell-penetrating properties of cationic peptides, Angew Chem Int Ed Engl, 56, 122, 10.1002/anie.201607649
Wada, 2011, Cellular uptake of Aib-containing amphipathic helix peptide, Bioorg Med Chem Lett, 21, 5688, 10.1016/j.bmcl.2011.08.030
Wada, 2016, Design of cyclic RGD-conjugated Aib-containing amphipathic helical peptides for targeted delivery of small interfering RNA, Bioorg Med Chem, 24, 4478, 10.1016/j.bmc.2016.07.040
Yamashita, 2016, A helix-stabilized cell-penetrating peptide as an intracellular delivery tool, ChemBioChem, 17, 137, 10.1002/cbic.201500468
Hyun, 2014, Apoptosis inducing, conformationally constrained, dimeric peptide analogs of KLA with submicromolar cell penetrating abilities, Biomacromolecules, 15, 3746, 10.1021/bm501026e
Blackwell, 1998, Highly efficient synthesis of covalently cross-linked peptide helices by ring closing metathesis, Angew Chem, 37, 3281, 10.1002/(SICI)1521-3773(19981217)37:23<3281::AID-ANIE3281>3.0.CO;2-V
Chang, 2013, Stapled alpha-helical peptide drug development: a potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy, PNAS, 110, E3445, 10.1073/pnas.1303002110
Walensky, 2004, Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix, Science, 305, 1466, 10.1126/science.1099191
Hilinski, 2014, Stitched alpha-helical peptides via bis ring-closing metathesis, Am Chem Soc, 136, 12314, 10.1021/ja505141j
Dougherty, 2017, Macrocycles as protein–protein interaction inhibitors, Biochem J, 474, 1109, 10.1042/BCJ20160619
White, 2016, Discovery and optimization of peptide macrocycles, Expert Opin Drug Discov, 11, 1151, 10.1080/17460441.2016.1245720
Lattig-Tunnemann, 2011, Backbone rigidity and static presentation of guanidinium groups increases cellular uptake of arginine-rich cell-penetrating peptides, Nat Commun, 2, 453, 10.1038/ncomms1459
Nischan, 2015, Covalent attachment of cyclic TAT peptides to GFP results in protein delivery into live cells with immediate bioavailability, Angew Chem, 54, 1950, 10.1002/anie.201410006
Traboulsi, 2015, Macrocyclic cell penetrating peptides: a study of structure-penetration properties, Bioconjug Chem, 26, 405, 10.1021/acs.bioconjchem.5b00023
Horn, 2016, Tuning the properties of a novel short cell-penetrating peptide by intramolecular cyclization with a triazole bridge, Chem Commun, 52, 2261, 10.1039/C5CC08938G
Reichart, 2016, Cyclization of a cell-penetrating peptide via click-chemistry increases proteolytic resistance and improves drug delivery, J Pept Sci, 22, 421, 10.1002/psc.2885
Qian, 2013, Efficient delivery of cyclic peptides into mammalian cells with short sequence motifs, ACS Chem Biol, 8, 423, 10.1021/cb3005275
Qian, 2014, Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery, Biochemistry, 53, 4034, 10.1021/bi5004102
Qian, 2016, Discovery and mechanism of highly efficient cyclic cell-penetrating peptides, Biochemistry, 55, 2601, 10.1021/acs.biochem.6b00226
Welch, 2016, Functional delivery of siRNA by disulfide-constrained cyclic amphipathic peptides, ACS Med Chem Lett, 7, 584, 10.1021/acsmedchemlett.6b00031
Francisco Hilario, 2017, Synthesis of an uncharged tetra-cyclopeptide acting as a transmembrane carrier: enhanced cellular and nuclear uptake, Org Lett, 19, 612, 10.1021/acs.orglett.6b03776
Wallbrecher, 2014, Exploration of the design principles of a cell-penetrating bicylic peptide scaffold, Bioconjug Chem, 25, 955, 10.1021/bc500107f
Timmerman, 2005, Rapid and quantitative cyclization of multiple peptide loops onto synthetic scaffolds for structural mimicry of protein surfaces, ChemBioChem, 6, 821, 10.1002/cbic.200400374
Qian, 2017, Enhancing the cell permeability and metabolic stability of peptidyl drugs by reversible bicyclization, Angew Chem, 56, 1525, 10.1002/anie.201610888
Craik, 1999, Plant cyclotides: a unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif1, J Mol Biol, 294, 1327, 10.1006/jmbi.1999.3383
Cascales, 2011, Identification and characterization of a new family of cell-penetrating peptides: cyclic cell-penetrating peptides, J Biol Chem, 286, 36932, 10.1074/jbc.M111.264424
D'Souza, 2014, Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: mCoTI-II and SFTI-1, Eur J Med Chem, 88, 10, 10.1016/j.ejmech.2014.06.047
Gao, 2016, Cellular uptake of a cystine-knot peptide and modulation of its intracellular trafficking, Sci Rep, 6, 35179, 10.1038/srep35179
Troeira Henriques, 2017, Cyclotide structure and function: the role of membrane binding and permeation, Biochemistry, 56, 669, 10.1021/acs.biochem.6b01212
Zhang, 2015, Taming cell penetrating peptides: never too old to teach old dogs new tricks, Mol Pharm, 12, 3105, 10.1021/acs.molpharmaceut.5b00428